跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rilaxia - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rilaxia
Approved
STANDARD
Rilaxia
XL Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2a2b4b9f57f77d54
Company
XL Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
2a2b4b9f57f77d54
Drug Approval Philippines Name
Rilaxia
Product Name
Rilaxia
Registration Number
DRP-5493-06
Brand Name
Rilaxia
Generic Name
Etoricoxib
Dosage Form
Film-Coated Tablet
Dosage Strength
120 mg
Manufacturer
XL Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
GX International, Inc.
Issuance Date
27 September 2024
Expiry Date
28 August 2029
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2a2b4b9f57f77d54
Type
Standard
Back to Philippines FDA Approvals